{
    "nctId": "NCT03217409",
    "officialTitle": "A Multicenter Clinical Trial to Compare the Efficacy and Safety Between Rosuvastatin/Ezetimibe Combination and Monotherapy of Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia",
    "inclusionCriteria": "* Subjects \u2265 19 or \u2264 75 years of age\n* Subjects undergoing treatment for type 2 diabetes\n* Subjects undergoing treatment of statin for hypercholesterolemia\n* Fasting LDL-C \u2264 250mg/dL at the screening visit\n* Fasting LDL-C \u226570mg/dL or \u2264 160mg/dL at the randomization visit\n* Fasting TG\\<500mg/dL\n* Must have minimum age of 19 Years\n* Must have maximum age of 75 Years",
    "exclusionCriteria": "* Subjects with hypersensitivity reaction to Statin and Ezetimibe\n* Subjects with severe kidney disease\n* Subjects with HIV positive result at the screening\n* Pregnant or breast-feeding subjects\n* Subjects with taking any medication affecting level of LDL (Fenofibrate, Omega 3 fatty aicd etc.)\n* Insulin-treated Subjects\n* Other exclusions applied"
}